Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.

Pavlovsky, S; Schvartzman, E; Lastiri, F; Magnasco, H; Corrado, C; Raslawski, E; Cancela, M E; Ardaiz, M C; Cerutti, I; Rosso, A; Bruno, S; Aranguren, P N; Salvarezza, A; Donato, H; Dibar, E; Zirone, S

Pavlovsky, S; Schvartzman, E; Lastiri, F; Magnasco, H; Corrado, C; Raslawski, E; Cancela, M E; Ardaiz, M C; Cerutti, I; Rosso, A; Bruno, S; Aranguren, P N; Salvarezza, A; Donato, H; Dibar, E; Zirone, S.

Affiliation

Pavlovsky S; Fundaleu, Centro de Internación e Investigación Clínica Angelica Ocampo, Buenos Aires, Argentina. fundaleu@datamarkets.com.ar

J Clin Oncol ; 15(7): 2652-8, 1997 Jul.

Article de En | MEDLINE | ID: mdl-9215837

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Hodgkin / Protocoles de polychimiothérapie antinéoplasique Type d'étude: Clinical_trials / Prognostic_studies Limites: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Langue: En Journal: J Clin Oncol Année: 1997 Type de document: Article Pays d'affiliation: Argentine Pays de publication: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links